P3 Health Partners Inc. (PIII)
NASDAQ: PIII · Real-Time Price · USD
9.69
-0.80 (-7.63%)
At close: May 20, 2026, 4:00 PM EDT
10.15
+0.46 (4.75%)
After-hours: May 20, 2026, 7:59 PM EDT
P3 Health Partners Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, P3 Health Partners stock has a consensus rating of "Buy" and an average price target of $8.50. The average 1-year stock price forecast is 12.28% lower than the current stock price, while the lowest is $3.00 (-69.04%) and the highest is $14 (+44.48%).
Price Target: $8.50 (-12.28%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for P3 Health Partners stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $4 → $14 | Strong Buy | Maintains | $4 → $14 | +44.48% | May 15, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $3 | Hold | Maintains | $8 → $3 | -69.04% | Apr 2, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $13 → $4 | Strong Buy | Maintains | $13 → $4 | -58.72% | Mar 27, 2026 |
| BTIG | BTIG | Hold Suspends n/a | Hold | Suspends | n/a | n/a | Dec 12, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $20 → $13 | Strong Buy | Maintains | $20 → $13 | +29.00% | Nov 17, 2025 |
Financial Forecast
Revenue This Year
1.58B
from 1.46B
Increased by 8.22%
Revenue Next Year
1.64B
from 1.58B
Increased by 3.55%
EPS This Year
-9.62
from -45.26
EPS Next Year
-2.62
from -9.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 1.6B | 1.7B |
| Avg | 1.6B | 1.6B |
| Low | 1.5B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 11.9% | 6.6% |
| Avg | 8.2% | 3.5% |
| Low | 3.6% | -0.5% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -9.01 | -2.70 |
| Avg | -9.62 | -2.62 |
| Low | -10.08 | -2.52 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.